Insurer Contact and Submission Information
The box at the bottom of page 1 holds the insurer's or PBM's contact and submission details. Company Bulletin 2021-09 told insurers to add this information before making the form available to providers, so use the copy posted by the patient's plan. The page also reminds you to read the plan's website for anything else its reviewers need and to send the form to the plan only, never to the Department of Insurance.
Standard Review Request or Expedited Review Request
At the top of page 2, check one review type. An expedited request certifies that a standard review period may seriously jeopardize the patient's life, health or ability to regain maximum function. Only for an expedited request, give the provider's direct contact phone number and your initials. The insurer then has 24 hours to respond to a completed, accurate urgent request, versus 72 hours for regular medication needs.
A) Reason for Request
Mark Initial Authorization Request, Renewal Request or DAW (dispense as written). The note under this section repeats that the form does not cover medical exceptions under Sections 25(a)(3) or 45.1 of the Managed Care Reform and Patient Rights Act, so a step therapy or formulary exception request needs the plan's own forms rather than this one.
B) Patient Demographics
Answer whether the patient is hospitalized, then enter the patient's name, date of birth, street address with unit or apartment, city, state, ZIP code, phone number and sex. Add the patient's health plan ID and, if applicable, the group number. Copy the ID exactly as it appears on the member card so the plan can match the request to the right coverage.
C) Prescribing Provider Information
Give the prescribing provider's name, NPI and specialty, plus a DEA number for controlled substance requests only. Enter an office contact name, phone, street address with suite, city, state and ZIP, and the contact fax. Email is optional, and the health plan provider ID is requested only if accessible. The plan uses these contact details for follow-up questions and to send its decision.
D) Pharmacy Information and E) Requested Prescription Drug Information
Section D asks only for the pharmacy name and phone. In Section E, enter the drug name, strength, dosing schedule and duration, a specific diagnosis with its ICD code, and, if applicable, the place of infusion or injection and the facility provider ID or NPI. Indicate whether the patient has already started the medication and when, and list the ingredients within the drug.
F) Rationale for Prior Authorization
Explain why the drug is needed, drawing on the history of present illness, past medical history and current medications. The form invites you to attach chart notes if they will assist the review. This is where reviewers look for the clinical case, and the instructions warn that insufficient clinical information may extend the review period or lead to an adverse determination.
G) Failed/Contraindicated Therapies and H) Other Pertinent Information
If applicable in your opinion, list prior drugs in Section G with strength, dosing schedule, duration and the adverse event or specific failure for each. Section H is optional space for other information you consider necessary, such as relevant diagnostic labs, measures and the patient's response to treatment. Specific dates, durations and outcomes help the reviewer apply the plan's criteria.
J) Representation
The prescribing provider prints a name, signs and dates the form, representing that the information is true, complete and fully disclosed to the best of their knowledge and belief. The form warns that providing false or deceptive information with intent to defraud may be insurance fraud. Page 4 is marked For Health Plan Use Only and records the approval, denial, reviewer and effective date.